The Patent Paradox: Why More Protection Doesn't Always Mean More Value

Drawing on his experience inside corporate leadership, Dilworth IP founder Michael P. Dilworth brings a business executive's perspective to decisions traditionally left to patent attorneys.

A company can own hundreds of patents and still leave its most valuable innovations exposed to competitors. Another can secure a commanding position in its market with only a handful. How is that possible? Because owning intellectual property and extracting business value from it are two very different things.

Michael Dilworth, Patent Stratigist & Founder of Dilworth IP

For Michael P. Dilworth, Founder and Managing Partner of Dilworth IP, the distinction is central to how companies should approach innovation. Patents are frequently treated as evidence of technological strength, and a growing portfolio can certainly suggest an active research operation. But numbers reveal surprisingly little about whether a business is protecting the products, processes and capabilities that give it an edge.

"The goal is not to own the most patents. The goal is to own the rights that give the business control where control matters," said Dilworth.

It's a perspective informed by his experience as chief intellectual property counsel for a publicly traded industrial company with a substantial global patent portfolio. In that role, Dilworth was responsible not only for securing intellectual property rights but also for managing budgets, evaluating international protection and explaining investment decisions to corporate leadership. He saw firsthand how easily legal activity could become disconnected from commercial priorities.

A patent might protect a technically impressive invention without doing much to preserve the company's market position. Meanwhile, an innovation essential to a profitable product or manufacturing operation could remain inadequately protected. The disconnect is easy to miss when success is measured primarily by how many patents the company obtains.

Consider a manufacturer that has spent years patenting improvements to an established product line. Its portfolio continues to grow, along with the expenses required to maintain it. Yet the company's future increasingly depends on a newer production process that reduces costs and improves efficiency. If its intellectual property strategy hasn't kept pace, the business may be spending heavily to protect yesterday's technology while leaving tomorrow's advantage vulnerable.

That scenario illustrates a larger issue: intellectual property decisions cannot be separated from the direction of the business.

At Dilworth IP, the analysis begins with commercial objectives. Where does the company expect its next phase of growth? Which technologies make that growth possible? What would competitors need to reproduce to challenge its position? Only after answering those questions does the discussion turn to the most effective forms of protection.

Sometimes the answers are counterintuitive. In chemical manufacturing, for example, the most valuable patent may not cover the broadest scientific discovery. It might protect a specific combination of materials, operating conditions or equipment that makes production economically viable. The claims may be narrower, but if competitors cannot readily achieve comparable results without using that approach, the patent can provide meaningful commercial protection.

This is where technical sophistication and business significance can diverge. An invention may be remarkable from an engineering standpoint yet peripheral to the company's financial future. Another may seem incremental but prove essential to delivering a product at the quality, scale or cost customers expect.

Understanding the difference becomes particularly important when companies evaluate patents they already own. Portfolios often reflect years of research programs, acquisitions and shifting commercial priorities. Some rights remain central to the business. Others protect technologies that have lost their relevance, even as filing and maintenance expenses continue.

"The right question is not simply, 'Is this patent worth keeping?' It is, 'Is this the best use of the next dollar in the IP budget?'" Dilworth explains.

That's a capital allocation question as much as a legal one. Maintaining a patent has an opportunity cost, particularly when those resources could support protection for an emerging technology, a strategically important market or a more pressing competitive risk.

The goal isn't necessarily to have fewer patents. Some companies require extensive protection across multiple technologies and jurisdictions. What matters is knowing why each significant investment deserves a place in the portfolio.

And sometimes, the best protection doesn't involve a patent at all.

For manufacturing techniques, specialized processes and other innovations that competitors cannot easily reverse engineer, trade secrets may offer advantages that patent protection cannot. A patent generally requires public disclosure in exchange for a limited period of exclusivity. A trade secret can potentially remain protected indefinitely, provided the information meets the legal requirements and the company takes reasonable measures to preserve its confidentiality.

That distinction makes careful documentation, employee agreements, access restrictions and disclosure practices essential. Choosing not to patent an innovation should be an informed decision, not an oversight that leaves valuable knowledge unprotected.

Competitor patents demand similarly thoughtful analysis. A rival with thousands of filings may look formidable, but the real question is whether its enforceable claims cover technology the company needs to operate. Can the business design around those rights? Are they relevant to its markets? Do the filings reveal where the competitor intends to invest next?

These considerations belong in the boardroom as well as the legal department. Financial leaders understand capital priorities. Engineers know which technical capabilities are difficult to replicate. Commercial executives understand what customers value and where competitive pressure is building. Together, these perspectives can produce a far more useful intellectual property strategy than reviewing a list of patents in isolation.

Dilworth encourages companies to examine their portfolios alongside their business roadmaps, identifying which innovations support future revenue, where meaningful protection is missing and which existing rights no longer justify continued investment.

The exercise can expose uncomfortable truths. A company may discover that its most heavily patented technology contributes little to its next stage of growth, while a commercially critical process has received insufficient attention. Better to recognize that imbalance during a strategic review than after a competitor exploits it.

It also raises a question about how intellectual property success should be measured. Patent applications and grants can demonstrate innovation activity, but they don't automatically establish commercial value. A more useful assessment considers whether the portfolio helps protect revenue, preserve margins, support licensing opportunities or strengthen the company's position during negotiations.

Some of those benefits are difficult to quantify. A patent that deters a competitor may never produce a licensing payment, yet it can still be valuable if it helps preserve the company's market position.

"Innovation alone does not guarantee durable advantage," Dilworth shares. "If competitors can copy the commercially important parts of what a company has built, the company may create value for the market without retaining enough of that value for itself."

That observation captures a problem many innovation-driven businesses eventually confront. Developing something new is one achievement. Ensuring the company can retain a meaningful share of the value it creates is another.

For Dilworth, intellectual property strategy is ultimately about recognizing that difference and making deliberate choices about where legal protection can strengthen the business. It's a practical philosophy shaped by the realities of corporate budgets, competitive markets and the limits of what any patent portfolio can accomplish.

The most impressive collection of patents isn't necessarily the most valuable one. What matters is whether those rights protect something competitors need, customers value and the business cannot afford to surrender.

After all, a patent is only as strategically important as the advantage it helps a company keep.